Temat: "Brain Neoplasms" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases.
Autorzy:: Kibe Y; Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Ohka F; Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. .
Aoki K; Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Yamaguchi J; Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Motomura K; Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Ito E; Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Takeuchi K; Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Nagata Y; Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Ito S; Department of Neurosurgery, Konan Kosei Hospital, 137 Oomatsubara, Takaya-cho, Konan, 483-8703, Japan.
Mizutani N; Department of Neurosurgery, Konan Kosei Hospital, 137 Oomatsubara, Takaya-cho, Konan, 483-8703, Japan.
Shiba Y; Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Maeda S; Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Nishikawa T; Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Shimizu H; Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Saito R; Department of Neurosurgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Apr 11; Vol. 12 (1), pp. 57. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/genetics
Glioblastoma*/pathology
Li-Fraumeni Syndrome*/genetics
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioma*/genetics
Glioma*/pathology
Cerebellar Neoplasms*/genetics
Adult ; Humans ; Child ; Genes, p53 ; Mutation/genetics ; Isocitrate Dehydrogenase/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Rational and design of prophylactic cranial irradiation (PCI) and brain MRI surveillance versus brain MRI surveillance alone in patients with limited-stage small cell lung cancer achieving complete remission (CR) of tumor after chemoradiotherapy: a multicenter prospective randomized study.
Autorzy:: Chen M; Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
Li R; Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
Kong Y; Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
Shi L; Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
Wang J; Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
Wang Y; Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
Xu Y; Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
Ji Y; Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
Hu X; Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 08; Vol. 24 (1), pp. 429. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:: Small Cell Lung Carcinoma*/diagnostic imaging
Small Cell Lung Carcinoma*/therapy
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/therapy
Brain Neoplasms*/therapy
Brain Neoplasms*/prevention & control
Humans ; Adolescent ; Prospective Studies ; Retrospective Studies ; Magnetic Resonance Imaging ; Chemoradiotherapy/adverse effects ; Cranial Irradiation/adverse effects ; Pathologic Complete Response ; Brain/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases.
Autorzy:: Jiang J; Department of Health Service, Base of Health Service, Air Force Medical University, Xi'an, China.; Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, China.
Lu Y; Department of Respiratory and Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing, 210009, China. .
Chu J; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Air Force Medical University, Xi'an, China.
Zhang X; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Air Force Medical University, Xi'an, China.
Xu C; Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, China.
Liu S; Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, China.
Wan Z; Department of Hematology, Tangdu Hospital, Air Force Medical University, Xi'an, China.
Wang J; Basic Medicine School, Air Force Medical University, Xi'an, China.
Zhang L; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Air Force Medical University, Xi'an, China.
Liu K; Department of Health Service, Base of Health Service, Air Force Medical University, Xi'an, China.
Liu Z; Department of Health Service, Base of Health Service, Air Force Medical University, Xi'an, China.
Yang A; State Key Laboratory of Cancer Biology, Department of Immunology, Air Force Medical University, Xi'an, Shaanxi, 710032, China.
Ren X; Department of Respiratory and Critical Care Medicine, Shenzhen General Hospital, Shenzhen University, Shenzhen, China.
Zhang R; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Air Force Medical University, Xi'an, China. .; State Key Laboratory of Cancer Biology, Department of Immunology, Air Force Medical University, Xi'an, Shaanxi, 710032, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Apr 08; Vol. 22 (1), pp. 159. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/therapy
Lung Neoplasms*/metabolism
Carcinoma, Non-Small-Cell Lung*/therapy
Carcinoma, Non-Small-Cell Lung*/metabolism
Exosomes*/metabolism
Brain Neoplasms*/therapy
Brain Neoplasms*/pathology
Animals ; Humans ; RNA, Small Interfering/pharmacology ; HEK293 Cells ; Cell Line, Tumor ; ErbB Receptors/genetics ; ErbB Receptors/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
Autorzy:: Yabo YA; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.
Moreno-Sanchez PM; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.
Pires-Afonso Y; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.; Neuro-Immunology Group, Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg.
Kaoma T; Bioinformatics Platform, Department of Medical Informatics, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.
Nosirov B; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.; Multiomics Data Science, Department of Cancer Research, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.
Scafidi A; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.; Neuro-Immunology Group, Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg.
Ermini L; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.
Lipsa A; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.
Oudin A; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.
Kyriakis D; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4362, Esch-sur-Alzette, Luxembourg.
Grzyb K; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4362, Esch-sur-Alzette, Luxembourg.
Poovathingal SK; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4362, Esch-sur-Alzette, Luxembourg.; Single Cell Analytics & Microfluidics Core, Vlaams Instituut Voor Biotechnologie-KU Leuven, 3000, Louvain, Belgium.
Poli A; Neuro-Immunology Group, Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg.
Muller A; Bioinformatics Platform, Department of Medical Informatics, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.
Toth R; Bioinformatics Platform, Department of Medical Informatics, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.; Multiomics Data Science, Department of Cancer Research, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.
Klink B; National Center of Genetics, Laboratoire National de Santé, L-3555, Dudelange, Luxembourg.; Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg.; German Cancer Consortium (DKTK): Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT/UCC), Cancer Consortium (DKTK) Partner Site Dresden, and German Cancer Research Center (DKFZ), Dresden, Heidelberg, 01307, Germany.; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Berchem G; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.; Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg.; Centre Hospitalier Luxembourg, L-1210, Luxembourg, Luxembourg.
Berthold C; Centre Hospitalier Luxembourg, L-1210, Luxembourg, Luxembourg.
Hertel F; Centre Hospitalier Luxembourg, L-1210, Luxembourg, Luxembourg.
Mittelbronn M; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4362, Esch-sur-Alzette, Luxembourg.; Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg.; Luxembourg Center of Neuropathology (LCNP), L-3555, Dudelange, Luxembourg.; National Center of Pathology (NCP), Laboratoire National de Santé, L-3555, Dudelange, Luxembourg.
Heiland DH; Translational Neurosurgery, Friedrich-Alexander University Erlangen Nuremberg, 91054, Erlangen, Germany.; Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen Nuremberg, 91054, Erlangen, Germany.; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.; Department of Neurosurgery, Medical Center, University of Freiburg, 79106, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, 79106, Freiburg, Germany.
Skupin A; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4362, Esch-sur-Alzette, Luxembourg.; Department of Physics and Material Science, University Luxembourg, L-4367, Belvaux, Luxembourg.; Department of Neuroscience, University of California San Diego, La Jolla, CA, 92093, USA.
Nazarov PV; Bioinformatics Platform, Department of Medical Informatics, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.; Multiomics Data Science, Department of Cancer Research, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.
Niclou SP; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.
Michelucci A; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg. .; Neuro-Immunology Group, Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg. .; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4362, Esch-sur-Alzette, Luxembourg. .
Golebiewska A; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg. .; Pokaż więcej
Źródło:: Genome medicine [Genome Med] 2024 Apr 02; Vol. 16 (1), pp. 51. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/genetics
Glioblastoma*/metabolism
Brain Neoplasms*/genetics
Brain Neoplasms*/metabolism
Mice ; Animals ; Humans ; Microglia/metabolism ; Ecosystem ; Heterografts ; Phenotype ; Disease Models, Animal ; Dendritic Cells/metabolism ; Tumor Microenvironment/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study.
Autorzy:: Jambor I; Department of Radiology, University of Turku, Turku, Finland.; Enterprise Service Group-Radiology, Mass General Brigham, Boston, MA, United States of America.
Steiner A; Department of Radiology, University of Turku, Turku, Finland.; Medical Imaging Centre of Southwest Finland, Turku University Hospital, Turku, Finland.
Pesola M; Department of Radiology, University of Turku, Turku, Finland.
Gardberg M; Tyks Laboratories, Pathology, Turku University Hospital and Institute of Biomedicine, University of Turku Turku, Finland.
Frantzén J; Division of Clinical Neurosciences, Department of Neurosurgery, Turku University Hospital and University of Turku, Turku, Finland.
Jokinen P; Division of Clinical Neurosciences, Department of Neurosurgery, Turku University Hospital and University of Turku, Turku, Finland.
Liimatainen T; Department of Radiology, University of Oulu, Oulu, Finland.; Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Minn H; Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland.; Turku PET Centre, Turku University and Turku University Hospital, Turku, Finland, Finland.
Aronen H; Department of Radiology, University of Turku, Turku, Finland.; Medical Imaging Centre of Southwest Finland, Turku University Hospital, Turku, Finland.
Merisaari H; Department of Radiology, University of Turku, Turku, Finland.; Medical Imaging Centre of Southwest Finland, Turku University Hospital, Turku, Finland.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 01; Vol. 19 (4), pp. e0296958. Date of Electronic Publication: 2024 Apr 01 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/pathology
Glioma*/diagnostic imaging
Glioma*/pathology
Humans ; Feasibility Studies ; Prospective Studies ; Magnetic Resonance Imaging/methods ; Mutation ; Chromosome Aberrations ; Isocitrate Dehydrogenase/genetics ; Chromosomes, Human, Pair 1 ; Chromosomes, Human, Pair 19

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Hypoxia drives shared and distinct transcriptomic changes in two invasive glioma stem cell lines.
Autorzy:: Marallano VJ; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Ughetta ME; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Tejero R; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Nanda S; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Ramalingam R; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Stalbow L; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Sattiraju A; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Huang Y; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Ramakrishnan A; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Shen L; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Wojcinski A; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA.
Kesari S; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA.
Zou H; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Tsankov AM; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. .
Friedel RH; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 27; Vol. 14 (1), pp. 7246. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioma*/pathology
Glioblastoma*/pathology
Humans ; Hypoxia/genetics ; Hypoxia/metabolism ; Cell Line, Tumor ; Gene Expression Profiling ; Neoplastic Stem Cells/metabolism ; Cell Hypoxia/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Potential diagnostic and drug target markers in glioblastoma.
Autorzy:: Ahsan H; Department of Bioinformatics and Biosciences, Faculty of Health and Life Sciences, Capital University of Science and Technology (CUST), Islamabad, 44000, Pakistan.
Asghar M; Department of Biology, Lund University, Lund, Sweden. .; Department of Healthcare Biotechnology, Atta-Ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad, H-12, Pakistan. .
Malik SI; Department of Bioinformatics and Biosciences, Faculty of Health and Life Sciences, Capital University of Science and Technology (CUST), Islamabad, 44000, Pakistan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 27; Vol. 14 (1), pp. 7292. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/drug therapy
Glioblastoma*/genetics
Glioblastoma*/metabolism
Nisin*/metabolism
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Adult ; Humans ; Janus Kinases/metabolism ; Proteomics ; Signal Transduction ; STAT Transcription Factors/metabolism ; Granulocyte Colony-Stimulating Factor/metabolism ; Gene Expression Regulation, Neoplastic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Primary alveolar rhabdomyosarcoma of the brain: a case report.
Autorzy:: Al Mahmasani L; Division of Haematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Riad El Solh, P.O. Box: 11-0236, Beirut, 1107 2020, Lebanon.
Najjar M; Division of Neurosurgery, Department of Surgery, American University of Beirut Medical Centre, Beirut, Lebanon.
Hourany R; Department of Diagnostic Radiology, American University of Beirut Medical Centre, Beirut, Lebanon.
Tabbarah A; Department of Pathology, American University of Beirut Medical Centre, Beirut, Lebanon.
Sinno S; Department of Pathology, American University of Beirut Medical Centre, Beirut, Lebanon.
Chamseddine N; Division of Haematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Riad El Solh, P.O. Box: 11-0236, Beirut, 1107 2020, Lebanon.
Abou Zeidane R; Division of Haematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Riad El Solh, P.O. Box: 11-0236, Beirut, 1107 2020, Lebanon.
Amhaz G; Division of Haematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Riad El Solh, P.O. Box: 11-0236, Beirut, 1107 2020, Lebanon.
Youssef B; Department of Radiation Oncology, American University of Beirut Medical Centre, Beirut, Lebanon.
Assi HI; Division of Haematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Riad El Solh, P.O. Box: 11-0236, Beirut, 1107 2020, Lebanon. .; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2024 Mar 23; Vol. 18 (1), pp. 178. Date of Electronic Publication: 2024 Mar 23.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/surgery
Rhabdomyosarcoma*
Rhabdomyosarcoma, Alveolar*/diagnostic imaging
Rhabdomyosarcoma, Alveolar*/therapy
Rhabdomyosarcoma, Embryonal*/diagnosis
Adult ; Humans ; Male ; Brain/pathology ; Magnetic Resonance Imaging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases.
Autorzy:: Qi H; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Hou Y; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Zheng Z; Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, Shandong, China.
Zheng M; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Qiao Q; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Wang Z; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Sun X; Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, Shandong, China.
Xing L; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 21; Vol. 24 (1), pp. 362. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Genes, erbB-1 ; Nomograms ; Progression-Free Survival ; Radiomics ; Magnetic Resonance Imaging ; ErbB Receptors/genetics ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Protecting the Brain: Novel Strategies for Preventing Breast Cancer Brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood-Brain Barrier Models.
Autorzy:: Kirchner J; Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Würzburg University, Oberdürrbacher Str. 6, 97080 Würzburg, Germany.
Völker E; Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Würzburg University, Oberdürrbacher Str. 6, 97080 Würzburg, Germany.
Shityakov S; Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Würzburg University, Oberdürrbacher Str. 6, 97080 Würzburg, Germany.
Saji S; Department of Medical Oncology, Fukushima Medical University, 1 Hikarigaoka, Fukushima City 960-1295, Japan.
Förster CY; Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Würzburg University, Oberdürrbacher Str. 6, 97080 Würzburg, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 16; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/metabolism
Brain Neoplasms*/drug therapy
Brain Neoplasms*/prevention & control
Brain Neoplasms*/metabolism
Humans ; Female ; Blood-Brain Barrier/metabolism ; Estrogens/metabolism ; Estrogen Receptor beta/metabolism ; Endothelial Cells/metabolism ; Brain/metabolism ; Estradiol/pharmacology ; Estradiol/metabolism ; MCF-7 Cells ; Estrogen Receptor alpha/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Integrative multi-omics characterization reveals sex differences in glioblastoma.
Autorzy:: Jang B; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.
Yoon D; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.
Lee JY; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.
Kim J; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.
Hong J; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.
Koo H; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, South Korea.; Department of Clinical Research, Research Institute and Hospital, National Cancer Center, Goyang, South Korea.
Sa JK; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea. .; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea. .; Pokaż więcej
Źródło:: Biology of sex differences [Biol Sex Differ] 2024 Mar 16; Vol. 15 (1), pp. 23. Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/genetics
Glioblastoma*/metabolism
Glioblastoma*/pathology
Brain Neoplasms*/genetics
Brain Neoplasms*/metabolism
Brain Neoplasms*/pathology
Adult ; Humans ; Male ; Female ; Proteomics ; Multiomics ; Sex Characteristics ; ErbB Receptors ; Genomic Instability ; Aneuploidy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.
Autorzy:: Kahraman S; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey. .
Karakaya S; Department of Medical Oncology, Ankara Ataturk Sanatoryum Training and Research Hospital, Ankara, Turkey.
Kaplan MA; Department of Medical Oncology, Dicle University Medical Faculty Hospital, Diyarbakir, Turkey.
Goksu SS; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey.
Ozturk A; Department of Medical Oncology, Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey.
Isleyen ZS; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey.
Hamdard J; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey.
Yildirim S; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey.
Dogan T; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey.
Isik S; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Celebi A; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Gulbagci BB; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey.
Paksoy N; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Dogan M; Department of Medical Oncology, Ankara Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
Turk HM; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey.
Bilici A; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey.
Tatli AM; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey.
Akbas S; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey.
Turan N; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey.
Hacibekiroglu I; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey.
Dogu GG; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey.
Aydiner A; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Sumbul AT; Department of Medical Oncology, Baskent University Adana Dr. Turgut Noyan Application and Research Center, Adana, Turkey.
Akyurek S; Department of Radiation Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Yalciner M; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Demirkazik A; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Gursoy P; Department of Medical Oncology, Ege University Medical Faculty Hospital, Izmir, Turkey.
Aykan MB; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey.
Sahin E; Department of Medical Oncology, Kocaeli University Medical Faculty Hospital, Kocaeli, Turkey.
Karadag İ; Department of Medical Oncology, Hittite University Corum Training and Research Hospital, Corum, Turkey.
Kostek O; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Er MM; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey.
Artaç M; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey.
Duzkopru Y; Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey.
Aydin D; Department of Medical Oncology, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey.
Isik D; Department of Medical Oncology, Kocaeli Medical Park Hospital, Kocaeli, Turkey.
Karakas Y; Department of Medical Oncology, Acıbadem Bodrum Hospital, Mugla, Turkey.
Kilickap S; Department of Medical Oncology, Liv Hospital, Istinye University, Ankara, Turkey.
Erol C; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.
Demir B; Department of Medical Oncology, Aydin Ataturk State Hospital, Aydin, Turkey.
Civelek B; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Turkey.
Ergun Y; Department of Medical Oncology, Batman Training and Research Hospital, Batman, Turkey.
Akinci MB; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.
Dogan I; Department of Medical Oncology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Karadurmus N; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey.
Yumuk PF; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey.
Sendur MAN; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 09; Vol. 14 (1), pp. 5820. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Central Nervous System Neoplasms*/drug therapy
Humans ; Prognosis ; Retrospective Studies ; ErbB Receptors/genetics ; Treatment Outcome ; Protein Kinase Inhibitors/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: "sCT-Feasibility" - a feasibility study for deep learning-based MRI-only brain radiotherapy.
Autorzy:: Grigo J; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsstraße 27, DE- 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Szkitsak J; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsstraße 27, DE- 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Höfler D; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsstraße 27, DE- 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Fietkau R; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsstraße 27, DE- 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Putz F; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsstraße 27, DE- 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Bert C; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsstraße 27, DE- 91054, Erlangen, Germany. .; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany. .; Pokaż więcej
Źródło:: Radiation oncology (London, England) [Radiat Oncol] 2024 Mar 08; Vol. 19 (1), pp. 33. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:: Journal Article
MeSH Terms:: Deep Learning*
Radiotherapy, Intensity-Modulated*/methods
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/radiotherapy
Humans ; Feasibility Studies ; Retrospective Studies ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy Dosage ; Magnetic Resonance Imaging/methods ; Brain/diagnostic imaging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme.
Autorzy:: Meng J; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Qian W; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Department of Clinical Laborator, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, 215300, Suzhou, Jiangsu, China.
Yang Z; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Gong L; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Xu D; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Huang H; NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, 214063, Wuxi, China.
Jiang X; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Pu Z; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .
Yin Y; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .
Zou J; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 07; Vol. 24 (1), pp. 317. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioblastoma*/drug therapy
Glioblastoma*/genetics
Glioblastoma*/metabolism
Humans ; Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use ; Cell Line, Tumor ; Drug Resistance, Neoplasm/genetics ; E2F7 Transcription Factor/metabolism ; Prognosis ; Temozolomide/pharmacology ; Temozolomide/therapeutic use ; Tumor Suppressor Protein p53/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Brain tumour microstructure is associated with post-surgical cognition.
Autorzy:: Aznarez-Sanado M; School of Education and Psychology, University of Navarra, 31009, Pamplona, Spain.
Romero-Garcia R; Department of Medical Physiology and Biophysics, Instituto de Biomedicina de Sevilla (IBiS), HUVR/CSIC/Universidad de Sevilla/CIBERSAM, ISCIII, 41013, Sevilla, Spain. .; Department of Psychiatry, University of Cambridge, Herchel Smith Bldg, Robinson Way, Cambridge, CB2 0SZ, UK. .
Li C; Cambridge Brain Tumour Imaging Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK.; Department of Applied Mathematics and Theoretical Physics, The Centre for Mathematical Imaging in Healthcare, Cambridge, CB3 0WA, UK.; School of Medicine & School of Science and Engineering, University of Dundee, Dundee, DD1 4HN, UK.
Morris RC; Academic Neurosurgery Division, Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK.
Price SJ; Cambridge Brain Tumour Imaging Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK.
Manly T; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK.
Santarius T; Academic Neurosurgery Division, Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK.
Erez Y; Faculty of Engineering, Bar-Ilan University, 5290002, Ramat Gan, Israel.; The Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat Gan, Israel.
Hart MG; St George's, University of London and St George's University Hospitals NHS Foundation Trust, Institute of Molecular and Clinical Sciences, Neurosciences Research Centre, Cranmer Terrace, London, SW17 0RE, UK.
Suckling J; Department of Psychiatry, University of Cambridge, Herchel Smith Bldg, Robinson Way, Cambridge, CB2 0SZ, UK.; Cambridge and Peterborough NHS Foundation Trust, Cambridge, CB21 5EF, UK.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 07; Vol. 14 (1), pp. 5646. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/surgery
Brain Neoplasms*/pathology
Cognitive Dysfunction*
Female ; Humans ; Cognition ; Diffusion Magnetic Resonance Imaging/methods ; Cerebral Cortex/pathology ; Brain/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Morphological differentiation of peritumoral brain zone microglia.
Autorzy:: Salas-Gallardo GA; Laboratorio de Células Neurales Troncales, CIACYT-Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, San Luis Potosí, México.; Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México.
Lorea-Hernández JJ; Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México.
Robles-Gómez ÁA; Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México.
Del Campo CC; Laboratorio de Células Neurales Troncales, CIACYT-Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, San Luis Potosí, México.
Peña-Ortega F; Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0297576. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/pathology
Glioblastoma*/pathology
Rats ; Animals ; Microglia/pathology ; Rats, Sprague-Dawley ; Neoplasm Recurrence, Local/pathology ; Brain/diagnostic imaging ; Brain/pathology ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Identification and Validation of a PEX5-Dependent Signature for Prognostic Prediction in Glioma.
Autorzy:: Qin X; Department of Human Anatomy, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430070, China.
Wang B; Department of Human Anatomy, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430070, China.
Lu X; Department of Human Anatomy, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430070, China.
Song Y; Department of Human Anatomy, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430070, China.
Wang W; Department of Human Anatomy, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430070, China.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2024 Mar 06; Vol. 14 (3). Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/diagnosis
Brain Neoplasms*/genetics
Glioma*/diagnosis
Glioma*/genetics
Humans ; Mutation ; Peroxisome-Targeting Signal 1 Receptor/genetics ; Prognosis ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Using MRI radiomics to predict the efficacy of immunotherapy for brain metastasis in patients with small cell lung cancer.
Autorzy:: Shi X; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Wang P; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.; Cheeloo College of Medicine, Shandong University, Jinan, China.
Li Y; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Xu J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Yin T; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Teng F; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (9), pp. 738-748. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/drug therapy
Small Cell Lung Carcinoma*/diagnostic imaging
Small Cell Lung Carcinoma*/drug therapy
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/drug therapy
Humans ; Radiomics ; Immunotherapy ; Magnetic Resonance Imaging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Brain metastases from breast cancer using magnetic resonance imaging: A systematic review.
Autorzy:: Mohammadi M; Department of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mohammadi S; Department of Medical Sciences, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Hadizadeh H; Department of Radiology and Nuclear Medicine, School of Paramedical, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Olfati M; Department of Radiology and Nuclear Medicine, School of Paramedical, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Moradi F; Department of Energy Engineering & Physics, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran.
Tanzifi G; Department of Nuclear Engineering, Islamic Azad University, Central Tehran Branch, Tehran, Iran.
Ghaderi S; Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.; Pokaż więcej
Źródło:: Journal of medical radiation sciences [J Med Radiat Sci] 2024 Mar; Vol. 71 (1), pp. 133-141. Date of Electronic Publication: 2023 Aug 10.
Typ publikacji:: Journal Article; Systematic Review
MeSH Terms:: Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/secondary
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/pathology
Adult ; Female ; Humans ; Diffusion Tensor Imaging ; Magnetic Resonance Imaging/methods ; Magnetic Resonance Spectroscopy/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Low-dose GBCA administration for brain tumour dynamic contrast enhanced MRI: a feasibility study.
Autorzy:: Lewis D; Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. .; Geoffrey Jefferson Brain Research Centre, University of Manchester, Manchester, UK. .; Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. .; Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Stott Lane, Salford, Greater Manchester, M6 8HD, UK. .
Li KL; Geoffrey Jefferson Brain Research Centre, University of Manchester, Manchester, UK.; Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Waqar M; Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.; Geoffrey Jefferson Brain Research Centre, University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
Coope DJ; Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.; Geoffrey Jefferson Brain Research Centre, University of Manchester, Manchester, UK.; Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Pathmanaban ON; Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.; Geoffrey Jefferson Brain Research Centre, University of Manchester, Manchester, UK.; Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
King AT; Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.; Geoffrey Jefferson Brain Research Centre, University of Manchester, Manchester, UK.; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
Djoukhadar I; Department of Neuroradiology, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Zhao S; Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Cootes TF; Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Jackson A; Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Zhu X; Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 28; Vol. 14 (1), pp. 4905. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:: Journal Article
MeSH Terms:: Contrast Media*
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/pathology
Humans ; Feasibility Studies ; Magnetic Resonance Imaging/methods ; Brain/diagnostic imaging ; Brain/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Brain Neoplasms"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język